| Title |
IDH1 and IDH2 Mutations in Gliomas
|
|---|---|
| Published in |
Current Neurology and Neuroscience Reports, March 2013
|
| DOI | 10.1007/s11910-013-0345-4 |
| Pubmed ID | |
| Authors |
Adam L. Cohen, Sheri L. Holmen, Howard Colman |
X Demographics
The data shown below were collected from the profiles of 20 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 10% |
| Saudi Arabia | 2 | 10% |
| Spain | 2 | 10% |
| India | 1 | 5% |
| Colombia | 1 | 5% |
| United States | 1 | 5% |
| Turkey | 1 | 5% |
| Venezuela, Bolivarian Republic of | 1 | 5% |
| Kuwait | 1 | 5% |
| Other | 0 | 0% |
| Unknown | 8 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 60% |
| Scientists | 4 | 20% |
| Practitioners (doctors, other healthcare professionals) | 3 | 15% |
| Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 1,233 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 8 | <1% |
| United Kingdom | 5 | <1% |
| Germany | 3 | <1% |
| Brazil | 3 | <1% |
| Portugal | 2 | <1% |
| Italy | 1 | <1% |
| Sweden | 1 | <1% |
| South Africa | 1 | <1% |
| Finland | 1 | <1% |
| Other | 10 | <1% |
| Unknown | 1198 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 194 | 16% |
| Student > Master | 177 | 14% |
| Researcher | 155 | 13% |
| Student > Bachelor | 149 | 12% |
| Student > Doctoral Student | 94 | 8% |
| Other | 222 | 18% |
| Unknown | 242 | 20% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 306 | 25% |
| Biochemistry, Genetics and Molecular Biology | 215 | 17% |
| Agricultural and Biological Sciences | 186 | 15% |
| Neuroscience | 65 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 34 | 3% |
| Other | 138 | 11% |
| Unknown | 289 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2024.
All research outputs
#1,163,282
of 25,473,687 outputs
Outputs from Current Neurology and Neuroscience Reports
#42
of 993 outputs
Outputs of similar age
#8,542
of 210,520 outputs
Outputs of similar age from Current Neurology and Neuroscience Reports
#1
of 10 outputs
Altmetric has tracked 25,473,687 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 993 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,520 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them